ChemoTemp

University of Miami

An adverse effect of chemotherapy is that it lowers patients' white and red blood cell production as it attacks their rapidly dividing cancer cells. Progressive reduction in red blood cell counts leads to anemia, while reduction in white blood cells leaves an individual susceptible to infection. In the event of infection, mortality rates for chemotherapy patients can reach as high as 70% if the patients are not promptly treated with antibiotics. Thus, quick detection of infection is critical to maintaining chemotherapy patients' health. Because fever is an indicator of infection, chemotherapy patients and their caretakers must monitor patients' temperatures to ensure patient health. When fever is detected, patients require prompt medical attention.

The ChemoTemp E-Team has developed a fever monitoring and reporting device for chemotherapy patients. Although a variety of related technologies are available on the market to track fever, these products do not provide the comprehensive service offered by ChemoTemp. The device accurately measures patient temperature, identifies fever and risk of fever, and reports fever conditions to the patient and/or caregiver. Patients can wear ChemoTemp comfortably for long periods of time. The E-Team has nearly completed an alpha version of the device, and plan to finish circuit and algorithm developments in the next phase of the project. The E-Team has conducted a market and patent search and found that no like products exist on the market specifically for chemotherapy patients. The team consists of twenty-three undergraduate students from the Junior/Senior Engineering Clinic course, including students from electrical and computer engineering, mechanical engineering, and possibly life sciences students. These students work with a team of twelve graduate students and the clinic course professor.